Merck touts Phase III data for antibacterial Recarbrio; Sanofi to ax 200 jobs in Japan — report
→ According to an anonymous source who reported to Reuters, French drugmaker Sanofi plans to ax 200 jobs in Japan across sales, regulatory affairs …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
